Found: 10
Select item for more details and to access through your institution.
2497. Women's Perspectives on and Experiences with Long-acting Injectable Anti-retroviral Therapy in the United States and Spain: the Potential Role of Gender in Patient Preferences.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S866, doi. 10.1093/ofid/ofz360.2175
- By:
- Publication type:
- Article
Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Ombitasvir, Paritaprevir Co-dosed With Ritonavir, Dasabuvir, and Ribavirin for Hepatitis C in Patients Co-infected With HIV-1.
- Published in:
- JAMA: Journal of the American Medical Association, 2015, v. 313, n. 12, p. 1223, doi. 10.1001/jama.2015.1328
- By:
- Publication type:
- Article
Pre-Exposure Prophylaxis (PrEP) for HIV Infection: Results of a Survey of HIV Healthcare Providers Evaluating Their Knowledge, Attitudes, and Prescribing Practices.
- Published in:
- AIDS Patient Care & STDs, 2013, v. 27, n. 10, p. 553, doi. 10.1089/apc.2013.0173
- By:
- Publication type:
- Article
Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care providers participating in phase 3 trials.
- Published in:
- 2021
- By:
- Publication type:
- journal article
"It made me more confident that I have it under control": Patient and provider perspectives on moving to a two-drug ART regimen in the United States and Spain.
- Published in:
- PLoS ONE, 2020, v. 15, n. 5, p. 1, doi. 10.1371/journal.pone.0232473
- By:
- Publication type:
- Article
Switch to Stribild versus continuation of NVP or RPV with FTC and TDF in virologically suppressed HIV adults: a STRATEGY-NNRTI subgroup analysis.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19793
- By:
- Publication type:
- Article
Efficacy and Freedom: Patient Experiences with the Transition from Daily Oral to Long-Acting Injectable Antiretroviral Therapy to Treat HIV in the Context of Phase 3 Trials.
- Published in:
- AIDS & Behavior, 2020, v. 24, n. 12, p. 3473, doi. 10.1007/s10461-020-02918-x
- By:
- Publication type:
- Article
First Phase I human clinical trial of a killed whole-HIV-1 vaccine: demonstration of its safety and enhancement of anti-HIV antibody responses.
- Published in:
- Retrovirology, 2016, v. 13, p. 1, doi. 10.1186/s12977-016-0317-2
- By:
- Publication type:
- Article
Cabotegravir + Rilpivirine Every 2 Months Is Noninferior To Monthly: ATLAS-2M Study.
- Published in:
- Infection & Chemotherapy, 2020, v. 52, p. S378
- By:
- Publication type:
- Article